These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63 related articles for article (PubMed ID: 25916113)
1. [Role of syndecan-2 in amyloid plaque formation]. Leonova EI; Galzitskaia OV Mol Biol (Mosk); 2015; 49(1):89-98. PubMed ID: 25916113 [TBL] [Abstract][Full Text] [Related]
2. Design and evaluation of a 6-mer amyloid-beta protein derived phage display library for molecular targeting of amyloid plaques in Alzheimer's disease: Comparison with two cyclic heptapeptides derived from a randomized phage display library. Larbanoix L; Burtea C; Ansciaux E; Laurent S; Mahieu I; Vander Elst L; Muller RN Peptides; 2011 Jun; 32(6):1232-43. PubMed ID: 21575663 [TBL] [Abstract][Full Text] [Related]
3. Soluble amyloid-β precursor protein binds its cell surface receptor in a cooperative fashion with glypican and syndecan proteoglycans. Reinhard C; Borgers M; David G; De Strooper B J Cell Sci; 2013 Nov; 126(Pt 21):4856-61. PubMed ID: 23986479 [TBL] [Abstract][Full Text] [Related]
4. Glypican-1 as an Abeta binding HSPG in the human brain: its localization in DIG domains and possible roles in the pathogenesis of Alzheimer's disease. Watanabe N; Araki W; Chui DH; Makifuchi T; Ihara Y; Tabira T FASEB J; 2004 Jun; 18(9):1013-5. PubMed ID: 15084524 [TBL] [Abstract][Full Text] [Related]
5. Biochemical stages of amyloid-β peptide aggregation and accumulation in the human brain and their association with symptomatic and pathologically preclinical Alzheimer's disease. Rijal Upadhaya A; Kosterin I; Kumar S; von Arnim CA; Yamaguchi H; Fändrich M; Walter J; Thal DR Brain; 2014 Mar; 137(Pt 3):887-903. PubMed ID: 24519982 [TBL] [Abstract][Full Text] [Related]
6. Phage M13 for the treatment of Alzheimer and Parkinson disease. Messing J Gene; 2016 Jun; 583(2):85-89. PubMed ID: 26869319 [TBL] [Abstract][Full Text] [Related]
7. Alzheimer's disease: An alternative approach. Chandra SR Indian J Med Res; 2017 Jun; 145(6):723-729. PubMed ID: 29067973 [TBL] [Abstract][Full Text] [Related]
8. Perineuronal nets are largely unaffected in Alzheimer model Tg2576 mice. Morawski M; Pavlica S; Seeger G; Grosche J; Kouznetsova E; Schliebs R; Brückner G; Arendt T Neurobiol Aging; 2010 Jul; 31(7):1254-6. PubMed ID: 18829133 [TBL] [Abstract][Full Text] [Related]
9. The Arctic amyloid-β precursor protein (AβPP) mutation results in distinct plaques and accumulation of N- and C-truncated Aβ. Philipson O; Lord A; Lalowski M; Soliymani R; Baumann M; Thyberg J; Bogdanovic N; Olofsson T; Tjernberg LO; Ingelsson M; Lannfelt L; Kalimo H; Nilsson LN Neurobiol Aging; 2012 May; 33(5):1010.e1-13. PubMed ID: 22118948 [TBL] [Abstract][Full Text] [Related]
10. Novel mechanistic insight into the molecular basis of amyloid polymorphism and secondary nucleation during amyloid formation. Jeong JS; Ansaloni A; Mezzenga R; Lashuel HA; Dietler G J Mol Biol; 2013 May; 425(10):1765-81. PubMed ID: 23415897 [TBL] [Abstract][Full Text] [Related]
11. BRI2-BRICHOS is increased in human amyloid plaques in early stages of Alzheimer's disease. Del Campo M; Hoozemans JJ; Dekkers LL; Rozemuller AJ; Korth C; Müller-Schiffmann A; Scheltens P; Blankenstein MA; Jimenez CR; Veerhuis R; Teunissen CE Neurobiol Aging; 2014 Jul; 35(7):1596-604. PubMed ID: 24524963 [TBL] [Abstract][Full Text] [Related]
12. The amyloid hypothesis on trial. Makin S Nature; 2018 Jul; 559(7715):S4-S7. PubMed ID: 30046080 [No Abstract] [Full Text] [Related]
15. Accumulation of cellular prion protein within dystrophic neurites of amyloid plaques in the Alzheimer's disease brain. Takahashi RH; Tobiume M; Sato Y; Sata T; Gouras GK; Takahashi H Neuropathology; 2011 Jun; 31(3):208-14. PubMed ID: 21062360 [TBL] [Abstract][Full Text] [Related]
16. [The pathophysiology of Alzheimer's disease with special reference to "amyloid cascade hypothesis"]. Tamaoka A Rinsho Byori; 2013 Nov; 61(11):1060-9. PubMed ID: 24450113 [TBL] [Abstract][Full Text] [Related]